Downstream sample preparation for subsequent quality attribute analysis represents “a significant bottleneck in process development for non-antibody biologics,” wrote Kevin Brower, PhD, global head of ...

Today, the ability to obtain pure proteins is essential for developing targeted drugs, creating vaccines and understanding biological processes at a molecular level. The development and optimization ...

Creating analytical tools that support the advancement of knowledge can often come about through the integration of existing information and techniques, theoretical and practical, directed toward a ...